These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11312922)

  • 1. Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid: discovery of a novel aminoguanidinoacetic acid antidiabetic agent.
    Larsen SD; Connell MA; Cudahy MM; Evans BR; May PD; Meglasson MD; O'Sullivan TJ; Schostarez HJ; Sih JC; Stevens FC; Tanis SP; Tegley CM; Tucker JA; Vaillancourt VA; Vidmar TJ; Watt W; Yu JH
    J Med Chem; 2001 Apr; 44(8):1217-30. PubMed ID: 11312922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of aminoguanidine and diaminoguanidine analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid.
    Vaillancourt VA; Larsen SD; Tanis SP; Burr JE; Connell MA; Cudahy MM; Evans BR; Fisher PV; May PD; Meglasson MD; Robinson DD; Stevens FC; Tucker JA; Vidmar TJ; Yu JH
    J Med Chem; 2001 Apr; 44(8):1231-48. PubMed ID: 11312923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of quinoline carboxyguanidines as antidiabetic agents.
    Edmont D; Rocher R; Plisson C; Chenault J
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1831-4. PubMed ID: 10969979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
    Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
    J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines.
    Bahekar RH; Jain MR; Goel A; Patel DN; Prajapati VM; Gupta AA; Jadav PA; Patel PR
    Bioorg Med Chem; 2007 May; 15(9):3248-65. PubMed ID: 17339113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.
    Oudman I; Clark JF; Brewster LM
    PLoS One; 2013; 8(1):e52879. PubMed ID: 23326362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel substituted aminoalkylguanidines as potential antihyperglycemic and food intake-reducing agents.
    Tassoni E; Giannessi F; Brunetti T; Pessotto P; Renzulli M; Travagli M; Rajamäki S; Prati S; Dottori S; Corelli F; Cabri W; Carminati P; Botta M
    J Med Chem; 2008 Jun; 51(11):3073-6. PubMed ID: 18465847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.
    Oh S; Kim SJ; Hwang JH; Lee HY; Ryu MJ; Park J; Kim SJ; Jo YS; Kim YK; Lee CH; Kweon KR; Shong M; Park SB
    J Med Chem; 2010 Oct; 53(20):7405-13. PubMed ID: 20873794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent changes in cardiac muscle metabolism upon replacement of creatine by beta- guanidinopropionic acid.
    Field ML; Unitt JF; Radda GK; Henderson C; Seymour AM
    Biochem Soc Trans; 1991 Apr; 19(2):208S. PubMed ID: 1889584
    [No Abstract]   [Full Text] [Related]  

  • 10. Creatine kinase kinetics, ATP turnover, and cardiac performance in hearts depleted of creatine with the substrate analogue beta-guanidinopropionic acid.
    Shoubridge EA; Jeffry FM; Keogh JM; Radda GK; Seymour AM
    Biochim Biophys Acta; 1985 Oct; 847(1):25-32. PubMed ID: 4052460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists.
    Sinz C; Chang J; Lins AR; Brady E; Candelore M; Dallas-Yang Q; Ding V; Jiang G; Lin Z; Mock S; Qureshi S; Salituro G; Saperstein R; Shang J; Szalkowski D; Tota L; Vincent S; Wright M; Xu S; Yang X; Zhang B; Tata J; Kim R; Parmee E
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7131-6. PubMed ID: 22001094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.
    Oballa RM; Belair L; Black WC; Bleasby K; Chan CC; Desroches C; Du X; Gordon R; Guay J; Guiral S; Hafey MJ; Hamelin E; Huang Z; Kennedy B; Lachance N; Landry F; Li CS; Mancini J; Normandin D; Pocai A; Powell DA; Ramtohul YK; Skorey K; Sørensen D; Sturkenboom W; Styhler A; Waddleton DM; Wang H; Wong S; Xu L; Zhang L
    J Med Chem; 2011 Jul; 54(14):5082-96. PubMed ID: 21661758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the creatine analogue beta-guanidinopropionic acid on skeletal muscles of mice deficient in muscle creatine kinase.
    van Deursen J; Jap P; Heerschap A; ter Laak H; Ruitenbeek W; Wieringa B
    Biochim Biophys Acta; 1994 May; 1185(3):327-35. PubMed ID: 8180237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Nitroazolo[1,5-a]pyrimidin-7(4H)-ones as Antidiabetic Agents.
    Spasov AA; Babkov DA; Sysoeva VA; Litvinov RA; Shamshina DD; Ulomsky EN; Savateev KV; Fedotov VV; Slepukhin PA; Chupakhin ON; Charushin VN; Rusinov VL
    Arch Pharm (Weinheim); 2017 Dec; 350(12):. PubMed ID: 29152780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline.
    Le Bihan G; Rondu F; Pelé-Tounian A; Wang X; Lidy S; Touboul E; Lamouri A; Dive G; Huet J; Pfeiffer B; Renard P; Guardiola-Lemaître B; Manéchez D; Pénicaud L; Ktorza A; Godfroid JJ
    J Med Chem; 1999 May; 42(9):1587-603. PubMed ID: 10229628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 31P-nuclear magnetic resonance study of skeletal muscle metabolism in rats depleted of creatine with the analogue beta-guanidinopropionic acid.
    Shoubridge EA; Radda GK
    Biochim Biophys Acta; 1984 Sep; 805(1):79-88. PubMed ID: 6477974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GIP(Lys16PAL) and GIP(Lys37PAL): novel long-acting acylated analogues of glucose-dependent insulinotropic polypeptide with improved antidiabetic potential.
    Irwin N; O'Harte FP; Gault VA; Green BD; Greer B; Harriott P; Bailey CJ; Flatt PR
    J Med Chem; 2006 Feb; 49(3):1047-54. PubMed ID: 16451070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BVT.3531 reduces body weight and activates K(ATP) channels in isolated arcuate neurons in rats.
    Mirshamsi S; Olsson M; Arnelo U; Kinsella JM; Permert J; Ashford ML
    Regul Pept; 2007 Jun; 141(1-3):19-24. PubMed ID: 17346811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatine accumulation and exchange by HEK293 cells stably expressing high levels of a creatine transporter.
    Dodd JR; Zheng T; Christie DL
    Biochim Biophys Acta; 1999 Oct; 1472(1-2):128-36. PubMed ID: 10572933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.